{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:45:39Z","timestamp":1790214339138,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.hrthm.2011.08.009","type":"journal-article","created":{"date-parts":[[2011,8,14]],"date-time":"2011-08-14T16:01:12Z","timestamp":1313337672000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors"],"prefix":"10.1016","volume":"9","author":[{"given":"Barry J.","family":"Maron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Semsarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2011.08.009_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigm","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2011.08.009_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1540-8167.2007.00965.x","article-title":"Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics","volume":"19","author":"Alcalai","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2011.08.009_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2011.08.009_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2007.09.101","article-title":"Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high-risk status","volume":"101","author":"Maron","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high-risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib8","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jacc.2011.03.021","article-title":"Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy","volume":"57","author":"Maron","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib9","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.110.954446","article-title":"Is genotype clinically useful in predicting prognosis in hypertrophic cardiomyopathy?","volume":"122","author":"Landstrom","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2011.08.009_bib10","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/CIRCULATIONAHA.110.978924","article-title":"Is genotype clinically useful in predicting prognosis in hypertrophic cardiomyopathy","volume":"122","author":"Ho","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2011.08.009_bib11","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1161\/01.CIR.0000042675.59901.14","article-title":"Prevalence and severity of \u201cbenign\u201d mutations in the beta myosin heavy chain, cardiac troponin-T, and alpha tropomyosin genes in hypertrophic cardiomyopathy","volume":"106","author":"VanDriest","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2011.08.009_bib12","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0735-1097(02)01900-9","article-title":"Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T gene in hypertrophic cardiomyopathy","volume":"39","author":"Ackerman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00313029700169155","article-title":"Sudden cardiac death in familial hypertrophic cardiomyopathy: are benign mutations really benign?","volume":"29","author":"Semsarian","year":"1997","journal-title":"Pathology"},{"key":"10.1016\/j.hrthm.2011.08.009_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCGENETICS.108.836478","article-title":"Multiple mutations in genetic cardiovascular disease: a marker of disease severity?","volume":"2","author":"Kelly","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2011.08.009_bib15","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counseling","volume":"42","author":"Ingles","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.hrthm.2011.08.009_bib16","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/CIRCULATIONAHA.107.755777","article-title":"Severe heart failure and early mortality in a double mutation mouse model of familial hypertrophic cardiomyopathy","volume":"117","author":"Tsoutsman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2011.08.009_bib17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1253\/circj.CJ-10-0921","article-title":"Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"74","author":"Maron","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2011.08.009_bib20","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib21","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jacc.2004.05.088","article-title":"Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy","volume":"44","author":"Mogensen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1399-0004.2003.00151.x","article-title":"Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy","volume":"64","author":"Erdmann","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2011.08.009_bib23","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2011.08.009_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(01)01386-9","article-title":"Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations","volume":"38","author":"Maron","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib25","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2011.08.009_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jmg.36.7.542","article-title":"Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy","volume":"36","author":"Richard","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.hrthm.2011.08.009_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00246-007-9177-9","article-title":"Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutations","volume":"4","author":"Frazier","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2011.08.009_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.hrthm.2010.06.013","article-title":"Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study","volume":"7","author":"Itoh","year":"2010","journal-title":"Heart Rhythm"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527111009155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527111009155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:43:45Z","timestamp":1761547425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527111009155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1547527111009155"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2011.08.009","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2011.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}